Serious liver disease in a patient receiving methotrexate and leflunomide

Arthritis Rheum. 2000 Nov;43(11):2609-11. doi: 10.1002/1529-0131(200011)43:11<2609::AID-ANR32>3.0.CO;2-R.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Anti-Inflammatory Agents, Non-Steroidal / toxicity
  • Arthritis, Rheumatoid / drug therapy
  • Drug Therapy, Combination
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Immunosuppressive Agents / toxicity
  • Isoxazoles / therapeutic use*
  • Isoxazoles / toxicity
  • Leflunomide
  • Liver / enzymology
  • Liver Cirrhosis / chemically induced*
  • Male
  • Methotrexate / therapeutic use*
  • Methotrexate / toxicity
  • Middle Aged
  • Severity of Illness Index

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Immunosuppressive Agents
  • Isoxazoles
  • Leflunomide
  • Methotrexate